DarioHealth Corp.

NASDAQ: DRIO · Real-Time Price · USD
0.43
-0.07 (-14.51%)
At close: Aug 12, 2025, 3:59 PM

DarioHealth Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.75M 7.6M 7.42M 6.25M 5.76M 3.62M 3.52M 6.15M 7.07M 6.81M 6.61M 6.18M 8.06M 6.03M 5.63M 5.26M 3.6M
Cost of Revenue
2.87M 3.4M 3.55M 3.5M 3.33M 3.48M 2.91M 4.08M 3.9M 4.08M 4.8M 5.04M 4.07M 5.48M 4.8M 3.75M 2.51M
Gross Profit
3.88M 4.2M 3.88M 2.76M 2.43M 132K 610K 2.07M 3.17M 2.73M 1.8M 1.14M 3.98M 548K 826K 1.51M 1.08M
Operating Income
-9.41M -12.38M -12.03M -16.07M -17.26M -14.09M -15.55M -14.02M -12.41M -9.01M -14.57M -17.36M -15.87M -21.66M -22.5M -18M -14.33M
Interest Income
n/a 161K n/a n/a 390K 470K 534K 529K 335K 278K 198K n/a 4K 8K n/a n/a 9K
Pretax Income
14.07M -9.48M 14.61M -13.61M -9.17M -14.22M 16.9M -16.59M -12.82M -12.61M -15.63M -18.03M -15.92M -21.55M -22.44M -17.77M -14.97M
Net Income
14.07M -9.63M -12.33M -3.37M -7.17M -12M 16.9M -16.59M 12.41M -12.62M -16.69M -18.03M -15.96M -21.59M -22.44M -17.77M -14.97M
Selling & General & Admin
9.18M 10.59M 10.46M 12.02M 13.64M 10.15M 10.49M 10.87M 10.41M 6.96M 11.57M 14.36M 13.93M 16.9M 17.82M 15.77M 12.75M
Research & Development
4.11M 5.28M 5.45M 6.81M 6.64M 4.2M 5.67M 5.22M 5.17M 4.78M 4.8M 4.14M 5.93M 5.32M 5.51M 3.74M 2.65M
Other Expenses
n/a 92.15M -24.06M n/a -34.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
13.29M 108.02M -8.15M 18.83M -15.42M 14.22M 16.16M 16.09M 15.58M 11.74M 16.37M 18.49M 19.86M 22.21M 23.32M 19.51M 15.41M
Interest Expense
n/a 22K n/a n/a 920K 557K 23K 16K 1.12M 931K n/a n/a 26K 24K n/a n/a 43K
Selling & Marketing Expenses
5.87M 5.58M 6.73M 7.13M 6.91M 4.62M 6.36M 6.46M 6.34M 3.92M 7.57M 9.3M 9.54M 12.23M 10.7M 9.65M 7.13M
Cost & Expenses
16.16M 111.42M -4.61M 22.33M -12.1M 17.7M 19.06M 20.17M 19.47M 15.82M 21.18M 23.54M 23.93M 27.69M 28.13M 23.26M 17.92M
Income Tax Expense
n/a 155K -13K -10.24M -1.99M 64K -1.24M n/a -25.23M 3K 1.06M 1K 44K 32K n/a -59K n/a
Shares Outstanding (Basic)
67.18M 40.42M 40.42M 39.83M 34.44M 27.19M 28.82M 28.19M 27.57M 25.72M 22.87M 22.43M 19.62M 15.69M 16.47M 15.69M 14.03M
Shares Outstanding (Diluted)
67.18M 40.42M 40.42M 39.83M 34.44M 27.19M 28.82M 28.19M 27.57M 25.72M 22.97M 22.43M 19.62M 15.69M 16.47M 15.69M 14.03M
EPS (Basic)
0.14 0.36 0.36 -0.08 -0.2 -0.44 0.59 -0.59 0.45 -0.49 -0.73 -0.8 -0.81 -1.38 -1.36 -1.13 -1.07
EPS (Diluted)
0.14 0.36 0.36 -0.08 -0.2 -0.44 0.59 -0.59 0.45 -0.49 -0.73 -0.8 -0.81 -1.38 -1.36 -1.13 -1.07
EBITDA
-9.41M -9.53M -9.9M -14.35M -16.53M -12.33M -14.38M -12.8M -11.2M -10.43M -13.35M -16.15M -14.85M -20.74M -21.01M -16.89M -13.89M
EBIT
n/a -11.67M -12.03M -16.19M -17.86M -17.39M -15.55M -14.02M -12.41M -11.71M -14.57M -17.36M -15.92M -21.66M -22.5M -17.75M -14.33M
Depreciation & Amortization
n/a 2.13M 2.13M 1.84M 1.33M 1.33M 1.33M 1.32M 1.25M 1.25M 1.23M 1.28M 1.04M 793K 1.43M 859K 445K